logo

For the Inventor, By the Inventor

Miramar, FL, United States of America

Altor Bioscience Corporation


USPTO Granted Patents = 61

% Expired Patents = 9.8



Trademarks = 2

Forward Citations = 867

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Hing C Wong (59 out of 111 patents)

silverMedal Peter Rhode (46 out of 48 patents)

bronzeMedal Bai Liu (35 out of 39 patents)

4.  Xiaoyun Zhu (23 out of 27 patents)

5.  Wenxin Xu (15 out of 17 patents)

6.  Warren Marcus (11 out of 11 patents)

7.  Kai-ping Han (11 out of 12 patents)

8.  Kai-Ping Han (9 out of 10 patents)

9.  Robert Newman (8 out of 8 patents)

10.  Lijing You (8 out of 8 patents)

11.  Lin Kong (6 out of 7 patents)

12.  Kimberlyn F Card (5 out of 5 patents)

13.  Jon A Weidanz (4 out of 4 patents)

14.  Marilyn Fernandez (3 out of 3 patents)

15.  Linda A Sherman (3 out of 4 patents)


Core Competencies:
IL-15
Fusion Molecules
Cancer Treatment
HIV T-Cell Receptors
Immune Checkpoint Inhibitors
Multimeric Molecules
Neoplasia
BCG
Anti-CD20
IL-12
IL-18
IL-7

61 patents:

1. 12410224 - IL-15-based fusions to IL-7 and IL-21 (2025-09-09),
2. 12371472 - Multimeric IL-15 soluble fusion molecules and methods of making and using same (2025-07-29),
3. 12325734 - Human immunodeficiency virus-specific T cell receptors (2025-06-10),
4. 12318432 - BCG and IL-15 based molecules (2025-06-03),
5. 12268732 - IL-15-based molecules with anti-CD20 antibody and methods of use (2025-04-08),
6. 12268731 - Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG) (2025-04-08),
7. 12233116 - IL-15-based fusions to IL-12 and IL-18 (2025-02-25),
8. 12186372 - IL-15-based molecules and methods of treating a neoplasia (2025-01-07),
9. 12168680 - Fusion molecules and IL-15 variants (2024-12-17),
10. 12097244 - Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody (2024-09-24),
11. 11992516 - Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies (2024-05-28),
12. 11975059 - IL-15-based fusions to IL-12 and IL-18 (2024-05-07),
13. 11965007 - IL-15-based fusions to IL-7 and IL-21 (2024-04-23),
14. 11925676 - Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex (2024-03-12),
15. 11890323 - Method of treating cancer with composition comprising IL-15-based molecules and BCG (2024-02-06),
Company Overview
Altor Bioscience Corporation, based in Miramar, FL, specializes in the development of innovative therapies utilizing IL-15 fusion molecules. The company focuses on advancing cancer treatment and enhancing immune responses through its research on multimeric molecules and immune checkpoint inhibitors. Altor's work also extends to the development of therapies targeting HIV T-cell receptors and neoplasia, positioning it at the forefront of immunotherapy and cancer research.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Altor Bioscience Corporation USPTO Patent Assignee Logo
61 Patents

#1 in Miramar, FL

#132 in Florida

#5,914 in US

#11,923 in the World

Miramar, FL (US)
Miramar, FL, United States of America

Altor Bioscience Corporation

Forward Citations = 867

38 inventors:

goldMedal Hing C Wong (59 out of 111 patents)

silverMedal Peter Rhode (46 out of 48 patents)

bronzeMedal Bai Liu (35 out of 39 patents)

4.  Xiaoyun Zhu (23 out of 27 patents)

5.  Wenxin Xu (15 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altor Bioscience Corporation. Retrieved from https://idiyas.com/company/altor-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…